{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T05:11:39Z","timestamp":1781759499116,"version":"3.54.5"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Iraqi Ministry of Higher Education and Scientific Research"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.phrs.2016.06.028","type":"journal-article","created":{"date-parts":[[2016,7,3]],"date-time":"2016-07-03T03:47:49Z","timestamp":1467517669000},"page":"442-451","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"special_numbering":"C","title":["Pharmacological postconditioning against myocardial infarction with a slow-releasing hydrogen sulfide donor, GYY4137"],"prefix":"10.1016","volume":"111","author":[{"given":"Qutuba G.","family":"Karwi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Whiteman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1809-7029","authenticated-orcid":false,"given":"Roberta","family":"Torregrossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary F.","family":"Baxter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2016.06.028_bib0005","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1039\/C5MD00170F","article-title":"Investigating the generation of hydrogen sulfide from the phosphonamidodithioate slow-release donor GYY4137","volume":"6","author":"Alexander","year":"2015","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.phrs.2016.06.028_bib0010","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s00395-014-0452-7","article-title":"Distinct cardioprotective mechanisms of immediate, early and delayed ischaemic postconditioning","volume":"110","author":"Barsukevich","year":"2015","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.phrs.2016.06.028_bib0015","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1124\/jpet.105.092023","article-title":"Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes","volume":"316","author":"Bian","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2016.06.028_bib0020","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/cvr\/cvv129","article-title":"Cardioprotection by H2S engages a cGMP-dependent protein kinase G\/phospholamban pathway","volume":"106","author":"Bibli","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2016.06.028_bib0025","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.coph.2008.11.009","article-title":"Pharmacological targets revealed by myocardial postconditioning","volume":"9","author":"Burley","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.phrs.2016.06.028_bib0030","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/sj.bjp.0707409","article-title":"Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signaling","volume":"152","author":"Burley","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.06.028_bib0035","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00395-015-0527-0","article-title":"Meeting report from the 2nd International Symposium on New Frontiers in Cardiovascular Research. Protecting the cardiovascular system from ischemia: between bench and bedside","volume":"111","author":"Cabrera-Fuentes","year":"2016","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.phrs.2016.06.028_bib0040","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/CIRCRESAHA.109.199919","article-title":"Hydrogen sulfide mediates cardioprotection through Nrf2 signaling","volume":"105","author":"Calvert","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2016.06.028_bib0045","doi-asserted-by":"crossref","first-page":"H2693","DOI":"10.1152\/ajpheart.00853.2007","article-title":"S-allylcysteine mediates cardioprotection in an acute myocardial infarction rat model via a hydrogen sulfide-mediated pathway","volume":"293","author":"Chuah","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2016.06.028_bib0050","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00395-015-0500-y","article-title":"Hydrogen sulfide mediates the cardioprotective effects of gene therapy with PKG-Ialpha","volume":"110","author":"Das","year":"2015","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.phrs.2016.06.028_bib0055","doi-asserted-by":"crossref","first-page":"15560","DOI":"10.1073\/pnas.0705891104","article-title":"Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function","volume":"104","author":"Elrod","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2016.06.028_bib0060","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1124\/pr.113.008300","article-title":"Interaction of risk factors, comorbidities, and comedications with ischemia\/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning","volume":"66","author":"Ferdinandy","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.phrs.2016.06.028_bib0065","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1582-4934.2011.01357.x","article-title":"Inducible hydrogen sulfide synthesis in chondrocytes and mesenchymal progenitor cells: is H2S a novel cytoprotective mediator in the inflamed joint?","volume":"16","author":"Fox","year":"2012","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.phrs.2016.06.028_bib0070","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1097\/ALN.0b013e3181f97fec","article-title":"Sevoflurane-induced preconditioning: impact of protocol and aprotinin administration on infarct size and endothelial nitric-oxide synthase phosphorylation in the rat heart in vivo","volume":"113","author":"Fradorf","year":"2010","journal-title":"Anesthesiology"},{"key":"10.1016\/j.phrs.2016.06.028_bib0075","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3109\/09537104.2013.786823","article-title":"Effect of the hydrogen sulfide donor GYY4137 on platelet activation and microvascular thrombus formation in mice","volume":"25","author":"Grambow","year":"2014","journal-title":"Platelets"},{"key":"10.1016\/j.phrs.2016.06.028_bib0080","first-page":"2015","article-title":"Emerging role of hydrogen sulfide-microRNA cross-talk in cardiovascular diseases","volume":"00660","author":"Hackfort","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol. ajpheart"},{"key":"10.1016\/j.phrs.2016.06.028_bib0085","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/ndt\/gfv226","article-title":"Hydrogen sulfide accelerates the recovery of kidney tubules after renal ischemia\/reperfusion injury","volume":"30","author":"Han","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.phrs.2016.06.028_bib0090","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00395-009-0010-x","article-title":"The mitochondrial permeability transition pore as a target for preconditioning and postconditioning","volume":"104","author":"Hausenloy","year":"2009","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.phrs.2016.06.028_bib0095","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10741-007-9026-1","article-title":"Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection","volume":"12","author":"Hausenloy","year":"2007","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.phrs.2016.06.028_bib0100","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3892\/etm.2012.733","article-title":"Endogenous hydrogen sulfide mediates the cardioprotection induced by ischemic postconditioning in the early reperfusion phase","volume":"4","author":"Huang","year":"2012","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.phrs.2016.06.028_bib0105","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jss.2009.10.025","article-title":"Noradrenaline protects in vivo rat heart against infarction and ventricular arrhythmias via nitric oxide and reactive oxygen species","volume":"169","author":"Imani","year":"2011","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.phrs.2016.06.028_bib0110","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.001986","article-title":"Hydrogen sulfide levels and nuclear factor-erythroid 2-related factor 2 (NRF2) activity are attenuated in the setting of critical limb ischemia (CLI)","volume":"4","author":"Islam","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.phrs.2016.06.028_bib0115","doi-asserted-by":"crossref","first-page":"e86744","DOI":"10.1371\/journal.pone.0086744","article-title":"Leptin-induced endothelium-dependent vasorelaxation of peripheral arteries in lean and obese rats: role of nitric oxide and hydrogen sulfide","volume":"9","author":"Jamroz-Wisniewska","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2016.06.028_bib0120","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00395-005-0569-9","article-title":"Exogenous hydrogen sulfide (H2S) protects against regional myocardial ischemia-reperfusion injury-Evidence for a role of K ATP channels","volume":"101","author":"Johansen","year":"2006","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.phrs.2016.06.028_bib0125","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","article-title":"Animal research: reporting in vivo experiments: the ARRIVE guidelines","volume":"160","author":"Kilkenny","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.06.028_bib0130","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1073\/pnas.1321871111","article-title":"Hydrogen sulfide cytoprotective signaling is endothelial nitric oxide synthase-nitric oxide dependent","volume":"111","author":"King","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2016.06.028_bib0135","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1161\/CIRCULATIONAHA.112.000855","article-title":"H(2)S protects against pressure overload-induced heart failure via upregulation of endothelial nitric oxide synthase","volume":"127","author":"Kondo","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2016.06.028_bib0140","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13618-014-0020-0","article-title":"Hydrogen sulfide provides cardioprotection against myocardial\/ischemia reperfusion injury in the diabetic state through the activation of the RISK pathway","volume":"4","author":"Lambert","year":"2014","journal-title":"Med. Gas Res."},{"key":"10.1016\/j.phrs.2016.06.028_bib0145","doi-asserted-by":"crossref","first-page":"e21077","DOI":"10.1371\/journal.pone.0021077","article-title":"The slow-releasing hydrogen sulfide donor, GYY4137, exhibits novel anti-cancer effects in vitro and in vivo","volume":"6","author":"Lee","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2016.06.028_bib0150","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13578-015-0003-4","article-title":"Mediation of exogenous hydrogen sulfide in recovery of ischemic post-conditioning-induced cardioprotection via down-regulating oxidative stress and up-regulating PI3\u2fffK\/Akt\/GSK-3beta pathway in isolated aging rat hearts","volume":"5","author":"Li","year":"2015","journal-title":"Cell Biosci."},{"key":"10.1016\/j.phrs.2016.06.028_bib0155","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13578-015-0035-9","article-title":"Exogenous hydrogen sulfide restores cardioprotection of ischemic post-conditioning via inhibition of mPTP opening in the aging cardiomyocytes","volume":"5","author":"Li","year":"2015","journal-title":"Cell Biosci."},{"key":"10.1016\/j.phrs.2016.06.028_bib0160","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.freeradbiomed.2009.04.014","article-title":"GYY4137, a novel hydrogen sulfide-releasing molecule, protects against endotoxic shock in the rat","volume":"47","author":"Li","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.phrs.2016.06.028_bib0165","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1161\/CIRCULATIONAHA.107.753467","article-title":"Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide","volume":"117","author":"Li","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2016.06.028_bib0170","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.plaphy.2010.09.016","article-title":"A novel hydrogen sulfide donor causes stomatal opening and reduces nitric oxide accumulation","volume":"48","author":"Lisjak","year":"2010","journal-title":"Plant Physiol. Biochem."},{"key":"10.1016\/j.phrs.2016.06.028_bib0175","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1089\/ars.2011.4005","article-title":"Hydrogen sulfide in the mammalian cardiovascular system","volume":"17","author":"Liu","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.phrs.2016.06.028_bib0180","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1111\/bph.12246","article-title":"The hydrogen sulfide donor, GYY4137, exhibits anti-atherosclerotic activity in high fat fed apolipoprotein E(-\/-) mice","volume":"169","author":"Liu","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.06.028_bib0185","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/j.1476-5381.2010.00873.x","article-title":"Guidelines for reporting experiments involving animals: the ARRIVE guidelines","volume":"160","author":"Mcgrath","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.06.028_bib0190","doi-asserted-by":"crossref","first-page":"203","DOI":"10.7555\/JBR.28.20140037","article-title":"GYY4137 protects against myocardial ischemia and reperfusion injury by attenuating oxidative stress and apoptosis in rats","volume":"29","author":"Meng","year":"2015","journal-title":"J. Biomed. Res."},{"key":"10.1016\/j.phrs.2016.06.028_bib0195","doi-asserted-by":"crossref","first-page":"691070","DOI":"10.1155\/2015\/691070","article-title":"Hydrogen sulfide donor GYY4137 protects against myocardial fibrosis","volume":"2015","author":"Meng","year":"2015","journal-title":"Oxid. Med. Cell Longevity"},{"key":"10.1016\/j.phrs.2016.06.028_bib0200","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejphar.2009.05.023","article-title":"All in the timing: a comparison between the cardioprotection induced by H2S preconditioning and post-infarction treatment","volume":"616","author":"Pan","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.06.028_bib0205","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1111\/bph.12806","article-title":"Pharmacological tools for hydrogen sulphide research: a brief, introductory guide for beginners","volume":"172","author":"Papapetropoulos","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.06.028_bib0210","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/1755-5922.12128","article-title":"A novel hydrogen sulfide prodrug, SG1002, promotes hydrogen sulfide and nitric oxide bioavailability in heart failure patients","volume":"33","author":"Polhemus","year":"2015","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.phrs.2016.06.028_bib0215","doi-asserted-by":"crossref","first-page":"H2410","DOI":"10.1152\/ajpheart.00044.2012","article-title":"The polysulfide diallyl trisulfide protects the ischemic myocardium by preservation of endogenous hydrogen sulfide and increasing nitric oxide bioavailability","volume":"302","author":"Predmore","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2016.06.028_bib0220","doi-asserted-by":"crossref","first-page":"e46278","DOI":"10.1371\/journal.pone.0046278","article-title":"A new slow releasing, H(2)S generating compound, GYY4137 relaxes spontaneous and oxytocin-stimulated contractions of human and rat pregnant myometrium","volume":"7","author":"Robinson","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2016.06.028_bib0225","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/sj.bjp.0707540","article-title":"The hydrogen sulphide-releasing derivative of diclofenac protects against ischaemia-reperfusion injury in the isolated rabbit heart","volume":"153","author":"Rossoni","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.06.028_bib0230","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/SHK.0b013e318180ff89","article-title":"Anti-apoptotic and anti-inflammatory effects of hydrogen sulfide in a rat model of regional myocardial I\/R","volume":"31","author":"Sivarajah","year":"2009","journal-title":"Shock"},{"key":"10.1016\/j.phrs.2016.06.028_bib0235","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.pharmthera.2014.05.005","article-title":"Novel therapeutic strategies for cardioprotection","volume":"144","author":"Sluijter","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2016.06.028_bib0240","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jtcvs.2008.08.074","article-title":"Hydrogen sulfide therapy attenuates the inflammatory response in a porcine model of myocardial ischemia\/reperfusion injury","volume":"138","author":"Sodha","year":"2009","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.phrs.2016.06.028_bib0245","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11010-011-1044-6","article-title":"Nitric oxide synthase inhibition abrogates hydrogen sulfide-induced cardioprotection in mice","volume":"360","author":"Sojitra","year":"2012","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.phrs.2016.06.028_bib0250","article-title":"The cardioprotective effect of GYY4137, a novel H2S donor, in ischaemia reperfusion injury","volume":"93","author":"Suveren","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2016.06.028_bib0255","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00109-012-0873-4","article-title":"Hydrogen sulfide: a gasotransmitter of clinical relevance","volume":"90","author":"Vandiver","year":"2012","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.phrs.2016.06.028_bib0260","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jss.2013.02.051","article-title":"Dobutamine-mediated heme oxygenase-1 induction via PI3K and p38 MAPK inhibits high mobility group box 1 protein release and attenuates rat myocardial ischemia\/reperfusion injury in vivo","volume":"183","author":"Wang","year":"2013","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.phrs.2016.06.028_bib0265","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1089\/ars.2009.2899","article-title":"The effect of hydrogen sulfide donors on lipopolysaccharide-induced formation of inflammatory mediators in macrophages","volume":"12","author":"Whiteman","year":"2010","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.phrs.2016.06.028_bib0270","doi-asserted-by":"crossref","first-page":"H1310","DOI":"10.1152\/ajpheart.00339.2009","article-title":"Hydrogen sulfide protects cardiomyocytes from hypoxia\/reoxygenation-induced apoptosis by preventing GSK-3beta-dependent opening of mPTP","volume":"298","author":"Yao","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2016.06.028_bib0275","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1620\/tjem.226.275","article-title":"Hydrogen sulfide protects cardiomyocytes from myocardial ischemia-reperfusion injury by enhancing phosphorylation of apoptosis repressor with caspase recruitment domain","volume":"226","author":"Yao","year":"2012","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.phrs.2016.06.028_bib0280","doi-asserted-by":"crossref","first-page":"H1330","DOI":"10.1152\/ajpheart.00244.2008","article-title":"Endogenous hydrogen sulphide mediates the cardioprotection induced by ischemic postconditioning","volume":"295","author":"Yong","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2016.06.028_bib0285","first-page":"132","article-title":"Allitridum mimics effect of ischemic preconditioning by activation of protein kinase C","volume":"22","author":"Zhang","year":"2001","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.phrs.2016.06.028_bib0290","doi-asserted-by":"crossref","first-page":"H579","DOI":"10.1152\/ajpheart.01064.2002","article-title":"Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning","volume":"285","author":"Zhao","year":"2003","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2016.06.028_bib0295","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1248\/bpb.32.1406","article-title":"Cardioprotective effect of hydrogen sulfide in ischemic reperfusion experimental rats and its influence on expression of survivin gene","volume":"32","author":"Zhuo","year":"2009","journal-title":"Biol. Pharm. Bull."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816302493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816302493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T03:16:56Z","timestamp":1692415016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661816302493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":59,"alternative-id":["S1043661816302493"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2016.06.028","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological postconditioning against myocardial infarction with a slow-releasing hydrogen sulfide donor, GYY4137","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2016.06.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}